from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2303c/-

LFCtreatmentdescriptionclass of inhibitor

-0.597

Amikacinug/mL Amikacintranslation

-0.033

Cap5-10ug/mL Capreomycintranslation

-0.987

Rox10-50 ug/mL Roxithromycintranslation

0.468

SM2-5 ug/mL Streptomycintranslation

-0.060

Tet5-10 ug/mL Tetracyclinetranslation

-1.915

Rif0.2-5ug/mL Rifampicintranscription

-0.166

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.620

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.593

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.119

CPZ10-50 ug/mL Chlorpromazinerespiration

1.452

Clofazimine10-13 ug/mL Clofaziminerespiration

0.663

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.380

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.753

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.310

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.934

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.203

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.652

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.612

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.363

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.702

KCN5-20 ug/mL Potassium cyaniderespiration

-0.763

NaN30.2-2 mM Sodium aziderespiration

0.681

Nigericin50 uM Nigericinrespiration

0.041

TRC10-150 ug/mL Triclosanrespiration

0.253

TRZ10-25 ug/mL Thioridazinerespiration

-0.373

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.920

menadione6-10 ug/mL Menadionerespiration

0.448

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.882

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.274

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.014

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.887

NRP_1Non-replicating persistence stage 1dosRassociated

-0.033

Amp0.2mg/mL AmpicillincellWall

-0.420

Cephalexin20-100 ug/mL CephalexincellWall

-0.069

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.513

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.220

EMB10-20 ug/mL EthambutolcellWall

0.371

Eta12-40 ug/mL EthionamidecellWall

-0.010

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.063

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.735

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.606

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.568

BZA0.12 mg/mL BenzamidearomaticAmides

-0.849

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.337

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.241

H2O24 mM hydrogen peroxideDNAdamaging

-0.729

Levo10 ug/mL LevofloxacinDNAdamaging

-0.792

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.981

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.559

UVUV-irradiationDNAdamaging

1.257

ARP41-4 ug/mL Antitubercular compound ARP4?

0.048

Antimycin12.5-50 ug/mL Antimycin A?

0.760

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.277

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.047

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.912

PA8240.2-2 ug/mL PA-824?

0.350

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.412

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.101

Verapamil50 uM Verapamil?

0.951

mercaptoethanol2 mM 2-Mercaptoethanol?

0.209

methoxatin10-20 ug/mL Methoxatin?